Sodium‐glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failure

Sodium‐glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failure

Abstract Aims Compelling evidence from randomized trials has shown that sodium‐glucose cotransporter 2 inhibitors (SGLT2is) are effective in heart failure (HF) across the spectrum of left ventricular ejection fractions. However, there are very few studies with real‐world data. Methods and results A...

Full description

Bibliographic Details
Main Authors: Patric Karlström, Aldina Pivodic, Ulf Dahlström, Michael Fu
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:ESC Heart Failure
Subjects:
Effectiveness
Real world
Heart failure
SGLT2is
Online Access:https://doi.org/10.1002/ehf2.14582

Similar Items

Similar Items